|
End-of-day quote
NSE India S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 128.40 INR | +0.05% |
|
-2.02% | +83.43% |
Company Valuation: Valiant Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2024 | 2025 | 2026 |
|---|---|---|---|
| Market Cap 1 | 6,302 | 3,327 | 2,804 |
| Change | - | -47.2% | -15.74% |
| Enterprise Value (EV) 1 | 5,631 | 3,780 | 2,934 |
| Change | - | -32.87% | -22.38% |
| P/E | 1,725x | -150x | -79.4x |
| PBR | 2.66x | 1.42x | 0.9x |
| PEG | -17.4x | 0x | -2.9x |
| Capitalization / Revenue | 3.46x | 2.49x | 1.18x |
| EV / Revenue | 3.09x | 2.83x | 1.24x |
| EV / EBITDA | -65.5x | -77.6x | 43.2x |
| EV / EBIT | -54.3x | -55.8x | 303x |
| EV / FCF | -14.1x | -2.79x | -6.1x |
| FCF Yield | -7.11% | -35.9% | -16.4% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | 0.0841 | -0.51 | -0.65 |
| Distribution rate | - | - | - |
| Net sales 1 | 1,821 | 1,334 | 2,375 |
| EBITDA 1 | -85.98 | -48.7 | 67.99 |
| EBIT 1 | -103.7 | -67.72 | 9.695 |
| Net income 1 | 3.196 | -22.01 | -32.68 |
| Net Debt 1 | -671.1 | 452.9 | 130.6 |
| Reference price 2 | 145.05 | 76.58 | 51.62 |
| Nbr of stocks (in thousands) | 43,450 | 43,450 | 54,313 |
| Announcement Date | 17/07/24 | 01/09/25 | 03/09/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 73.19M | ||
| 39.81x | 5.37x | 21.86x | 0.97% | 84.34B | ||
| 33.9x | 5.12x | 21.9x | 1.89% | 43.75B | ||
| 24.23x | 2.87x | 15.02x | 2.16% | 34.63B | ||
| 15.4x | 1.6x | 8.95x | 2.72% | 33.66B | ||
| 39.5x | 7.1x | 18.82x | 1.57% | 32.38B | ||
| 14.82x | 1.41x | 8.73x | 2.15% | 26.34B | ||
| 39.37x | 9.54x | 29.25x | 2.26% | 23.89B | ||
| 26.39x | 2.84x | 11.55x | 1.7% | 18.98B | ||
| 7.64x | 2.16x | 4.3x | 3.43% | 16.1B | ||
| Average | 26.78x | 4.22x | 15.60x | 2.09% | 31.41B | |
| Weighted average by Cap. | 30.03x | 4.50x | 17.35x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VALIANTLAB Stock
- Valuation Valiant Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















